An investigation into contemporary factors influencing the outcome of pancreatic cancer
Dr Nicholas Mowbray, Singleton Hospital (Supported by Amser Justin Time)
Start date: March 2015 (Extended to March 2019)
Funded amount: £8,496
Pancreatic cancer affects 9.3 per 100,000 people in the UK and historically, always carried a poor prognosis. This is largely because Pancreatic cancer can have no symptoms until it is too late and then curative treatment is no longer an option.
In 2009 Pancreatic Cancer services in South Wales were centralised to the Abertawe Bro Morgannwg University (ABMU) Health Board in order to concentrate specialist knowledge and expertise.
A Multi-Disciplinary Team (MDT) consisting of Surgeons, Radiologists, Oncologists, pathologists, Gastroenterologists and Specialist Nurses was created to discuss all patients with pancreatic tumours from Mid and South Wales and decide the best course of treatment. This team meets weekly and is dealing with an increasing number of patients.
- The aim of this study is to identify how well we are treating Pancreatic Cancer in Wales. The specific aims include;
- Assessing how successful our pancreatic surgery is and also to identify how the surgical treatment could be improved in the future.
- Identify delays in the referral processes and how long it takes patients to be both diagnosed and offered treatment.
What are the patient views on the service that is provided and are there any areas for improvement.
Supported by Amser Justin Time
Dr Nicholas Mowbray, Morriston Hospital
Mr Al-Sarireh, Department of General Surgery, Morriston Hospital, Swansea
Mr TH Brown, Department of General Surgery, Morriston Hospital, Swansea
Prof. W Lewis, Department of General Surgery, University Hospital of Wales, Cardiff